Edwards Lifesciences CEO Zovighian Executes Pre-Arranged Stock Sale
Edwards Lifesciences Corp. (NASDAQ: EW) CEO Bernard J. Zovighian executed a transaction to sell 523 shares of company common stock, totaling $45,982, on June 17, 2026. The sale was conducted indirectly through a trust and adhered to a Rule 10b5-1 trading plan established by Mr. Zovighian on December 12, 2025. This transaction reduces his indirect t…